UPC Valuation
Universe Pharmaceuticals Inc
$
3.430
- Overview
- Forecast
- Valuation
- Earnings
UPC Relative Valuation
UPC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, UPC is overvalued; if below, it's undervalued.
Historical Valuation
Universe Pharmaceuticals Inc (UPC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Universe Pharmaceuticals Inc (UPC) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：3.47
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Universe Pharmaceuticals Inc. (UPC) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Universe Pharmaceuticals Inc. (UPC) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Universe Pharmaceuticals Inc. (UPC) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Universe Pharmaceuticals Inc. (UPC) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Universe Pharmaceuticals Inc. (UPC) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Universe Pharmaceuticals Inc (UPC) has a current Price-to-Book (P/B) ratio of 0.03. Compared to its 3-year average P/B ratio of 0.22 , the current P/B ratio is approximately -84.25% higher. Relative to its 5-year average P/B ratio of 0.41, the current P/B ratio is about -91.40% higher. Universe Pharmaceuticals Inc (UPC) has a Forward Free Cash Flow (FCF) yield of approximately -248.74%. Compared to its 3-year average FCF yield of -168.82%, the current FCF yield is approximately 47.34% lower. Relative to its 5-year average FCF yield of -123.58% , the current FCF yield is about 101.27% lower.
0.04
P/B
Median3y
0.22
Median5y
0.41
-248.52
FCF Yield
Median3y
-168.82
Median5y
-123.58
Competitors Valuation Multiple
The average P/S ratio for UPC's competitors is 0.02, providing a benchmark for relative valuation. Universe Pharmaceuticals Inc Corp (UPC) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of UPC increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of UPC in the past 1 year is driven by Unknown.
People Also Watch
FAQ
Is Universe Pharmaceuticals Inc (UPC) currently overvalued or undervalued?
Universe Pharmaceuticals Inc (UPC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Universe Pharmaceuticals Inc (UPC) is between to according to relative valuation methord.
What is Universe Pharmaceuticals Inc (UPC) fair value?
How does UPC's valuation metrics compare to the industry average?
What is the current P/B ratio for Universe Pharmaceuticals Inc (UPC) as of Aug 22 2025?
What is the current FCF Yield for Universe Pharmaceuticals Inc (UPC) as of Aug 22 2025?
What is the current Forward P/E ratio for Universe Pharmaceuticals Inc (UPC) as of Aug 22 2025?